Elelyso (taliglucerase alfa)

pCPA File Number: 20999
Negotiation Status:
Concluded with an LOI
Indication(s):
Gaucher disease
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: